BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34830398)

  • 1. Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
    Abdulmawjood B; Costa B; Roma-Rodrigues C; Baptista PV; Fernandes AR
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
    Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
    Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
    Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A complex three-way translocation with deletion of the TP53 gene in a blast crisis chronic myeloid leukemia patient.
    Kokate P; Dalvi R; Mandava S
    J Cancer Res Ther; 2015; 11(4):1037. PubMed ID: 26881646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelogenous leukemia: molecular and cellular aspects.
    Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
    J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML.
    Honda H; Ushijima T; Wakazono K; Oda H; Tanaka Y; Aizawa Si; Ishikawa T; Yazaki Y; Hirai H
    Blood; 2000 Feb; 95(4):1144-50. PubMed ID: 10666183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies.
    Warmuth M; Danhauser-Riedl S; Hallek M
    Ann Hematol; 1999 Feb; 78(2):49-64. PubMed ID: 10089019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TGF-beta type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression.
    Rooke HM; Vitas MR; Crosier PS; Crosier KE
    Leukemia; 1999 Apr; 13(4):535-41. PubMed ID: 10214859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activity of Fyn mediate proliferation and blastic features of chronic myelogenous leukemia.
    Singh MM; Howard A; Irwin ME; Gao Y; Lu X; Multani A; Chandra J
    PLoS One; 2012; 7(12):e51611. PubMed ID: 23284724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research advance on molecular genetics of CML blast crisis].
    Zhu HQ; Zhang S; Liu XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired immunomodulatory function of chronic myeloid leukemia cancer stem cells and the possible mechanism involved in it.
    Xishan Z; Xinna Z; Baoxin H; Jun R
    Cancer Immunol Immunother; 2013 Apr; 62(4):689-703. PubMed ID: 23180012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome abnormalities in CML.
    Hagemeijer A
    Baillieres Clin Haematol; 1987 Dec; 1(4):963-81. PubMed ID: 3332858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
    Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
    Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myeloid leukemia stem cells.
    Jamieson CH
    Hematology Am Soc Hematol Educ Program; 2008; ():436-42. PubMed ID: 19074122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Philadelphia chromosome in leukemogenesis.
    Kang ZJ; Liu YF; Xu LZ; Long ZJ; Huang D; Yang Y; Liu B; Feng JX; Pan YJ; Yan JS; Liu Q
    Chin J Cancer; 2016 May; 35():48. PubMed ID: 27233483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
    Becher R; Kloke O
    Verh Dtsch Ges Pathol; 1990; 74():36-42. PubMed ID: 1708614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
    Kolenova A; Maloney KW; Hunger SP
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):e193-5. PubMed ID: 27164534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.